270 related articles for article (PubMed ID: 35062337)
21. Friend or Foe? Implication of the autophagy-lysosome pathway in SARS-CoV-2 infection and COVID-19.
He W; Gao Y; Zhou J; Shi Y; Xia D; Shen HM
Int J Biol Sci; 2022; 18(12):4690-4703. PubMed ID: 35874956
[TBL] [Abstract][Full Text] [Related]
22. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
[TBL] [Abstract][Full Text] [Related]
23. GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma.
Brun S; Bassissi F; Serdjebi C; Novello M; Tracz J; Autelitano F; Guillemot M; Fabre P; Courcambeck J; Ansaldi C; Raymond E; Halfon P
Invest New Drugs; 2019 Dec; 37(6):1135-1145. PubMed ID: 30778887
[TBL] [Abstract][Full Text] [Related]
24. Lectin from
Auth J; Fröba M; Große M; Rauch P; Ruetalo N; Schindler M; Morokutti-Kurz M; Graf P; Dolischka A; Prieschl-Grassauer E; Setz C; Schubert U
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638545
[TBL] [Abstract][Full Text] [Related]
25. GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma
Brun S; Bestion E; Raymond E; Bassissi F; Jilkova ZM; Mezouar S; Rachid M; Novello M; Tracz J; Hamaï A; Lalmanach G; Vanderlynden L; Legouffe R; Stauber J; Schubert T; Plach MG; Courcambeck J; Drouot C; Jacquemot G; Serdjebi C; Roth G; Baudoin JP; Ansaldi C; Decaens T; Halfon P
Autophagy; 2022 Mar; 18(3):678-694. PubMed ID: 34740311
[TBL] [Abstract][Full Text] [Related]
26. Open questions for harnessing autophagy-modulating drugs in the SARS-CoV-2 war: hope or hype?
Brest P; Benzaquen J; Klionsky DJ; Hofman P; Mograbi B
Autophagy; 2020 Dec; 16(12):2267-2270. PubMed ID: 32521191
[TBL] [Abstract][Full Text] [Related]
27. Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture.
Bakovic A; Risner K; Bhalla N; Alem F; Chang TL; Weston WK; Harness JA; Narayanan A
Viruses; 2021 Feb; 13(2):. PubMed ID: 33572467
[TBL] [Abstract][Full Text] [Related]
28. Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity.
Kaptein SJF; Jacobs S; Langendries L; Seldeslachts L; Ter Horst S; Liesenborghs L; Hens B; Vergote V; Heylen E; Barthelemy K; Maas E; De Keyzer C; Bervoets L; Rymenants J; Van Buyten T; Zhang X; Abdelnabi R; Pang J; Williams R; Thibaut HJ; Dallmeier K; Boudewijns R; Wouters J; Augustijns P; Verougstraete N; Cawthorne C; Breuer J; Solas C; Weynand B; Annaert P; Spriet I; Vande Velde G; Neyts J; Rocha-Pereira J; Delang L
Proc Natl Acad Sci U S A; 2020 Oct; 117(43):26955-26965. PubMed ID: 33037151
[TBL] [Abstract][Full Text] [Related]
29. Autophagy, Unfolded Protein Response, and Neuropilin-1 Cross-Talk in SARS-CoV-2 Infection: What Can Be Learned from Other Coronaviruses.
Siri M; Dastghaib S; Zamani M; Rahmani-Kukia N; Geraylow KR; Fakher S; Keshvarzi F; Mehrbod P; Ahmadi M; Mokarram P; Coombs KM; Ghavami S
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206057
[TBL] [Abstract][Full Text] [Related]
30. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
[TBL] [Abstract][Full Text] [Related]
31. Persimmon-derived tannin has antiviral effects and reduces the severity of infection and transmission of SARS-CoV-2 in a Syrian hamster model.
Furukawa R; Kitabatake M; Ouji-Sageshima N; Suzuki Y; Nakano A; Matsumura Y; Nakano R; Kasahara K; Kubo K; Kayano SI; Yano H; Ito T
Sci Rep; 2021 Dec; 11(1):23695. PubMed ID: 34880383
[TBL] [Abstract][Full Text] [Related]
32. Quinacrine, an Antimalarial Drug with Strong Activity Inhibiting SARS-CoV-2 Viral Replication In Vitro.
Salas Rojas M; Silva Garcia R; Bini E; Pérez de la Cruz V; León Contreras JC; Hernández Pando R; Bastida Gonzalez F; Davila-Gonzalez E; Orozco Morales M; Gamboa Domínguez A; Sotelo J; Pineda B
Viruses; 2021 Jan; 13(1):. PubMed ID: 33477376
[TBL] [Abstract][Full Text] [Related]
33. Effects of simeprevir on the replication of SARS-CoV-2 in vitro and in transgenic hACE2 mice.
Muturi E; Hong W; Li J; Yang W; He J; Wei H; Yang H
Int J Antimicrob Agents; 2022 Jan; 59(1):106499. PubMed ID: 34929295
[TBL] [Abstract][Full Text] [Related]
34. SARS-CoV-2 M
Qiao J; Li YS; Zeng R; Liu FL; Luo RH; Huang C; Wang YF; Zhang J; Quan B; Shen C; Mao X; Liu X; Sun W; Yang W; Ni X; Wang K; Xu L; Duan ZL; Zou QC; Zhang HL; Qu W; Long YH; Li MH; Yang RC; Liu X; You J; Zhou Y; Yao R; Li WP; Liu JM; Chen P; Liu Y; Lin GF; Yang X; Zou J; Li L; Hu Y; Lu GW; Li WM; Wei YQ; Zheng YT; Lei J; Yang S
Science; 2021 Mar; 371(6536):1374-1378. PubMed ID: 33602867
[TBL] [Abstract][Full Text] [Related]
35. The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue.
Zimniak M; Kirschner L; Hilpert H; Geiger N; Danov O; Oberwinkler H; Steinke M; Sewald K; Seibel J; Bodem J
Sci Rep; 2021 Mar; 11(1):5890. PubMed ID: 33723270
[TBL] [Abstract][Full Text] [Related]
36. AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2
Good SS; Westover J; Jung KH; Zhou XJ; Moussa A; La Colla P; Collu G; Canard B; Sommadossi JP
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33558299
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air-Liquid Interface Cultured Human Primary Bronchial Epithelial Cells.
Ter Ellen BM; Dinesh Kumar N; Bouma EM; Troost B; van de Pol DPI; van der Ende-Metselaar HH; Apperloo L; van Gosliga D; van den Berge M; Nawijn MC; van der Voort PHJ; Moser J; Rodenhuis-Zybert IA; Smit JM
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372541
[TBL] [Abstract][Full Text] [Related]
38. The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses.
Schreiber A; Viemann D; Schöning J; Schloer S; Mecate Zambrano A; Brunotte L; Faist A; Schöfbänker M; Hrincius E; Hoffmann H; Hoffmann M; Pöhlmann S; Rescher U; Planz O; Ludwig S
Cell Mol Life Sci; 2022 Jan; 79(1):65. PubMed ID: 35013790
[TBL] [Abstract][Full Text] [Related]
39. Nitric Oxide to Fight Viral Infections.
Lisi F; Zelikin AN; Chandrawati R
Adv Sci (Weinh); 2021 Apr; 8(7):2003895. PubMed ID: 33850691
[TBL] [Abstract][Full Text] [Related]
40. Incomplete antiviral treatment may induce longer durations of viral shedding during SARS-CoV-2 infection.
Kim KS; Iwanami S; Oda T; Fujita Y; Kuba K; Miyazaki T; Ejima K; Iwami S
Life Sci Alliance; 2021 Oct; 4(10):. PubMed ID: 34344719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
